Defining Low-threshold Buprenorphine Treatment
2019 · Journal of Addiction Medicine · 202 citations
https://doi.org/10.1097/adm.0000000000000555
A
Aaron D. Fox
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
91
Papers
2.1K
Citations
26
h-index
44
i10-index
Aaron D. Fox is an academic researcher from Albert Einstein College of Medicine. The author has contributed to research in topics: Opioid Use Disorder Treatment & Substance Abuse Treatment and Outcomes & HIV, Drug Use, Sexual Risk. The author has an h-index of 26, co-authored 78 publications.
ORCID: 0000-0002-6904-4795Papers by this author
worksA conceptual model for understanding post-release opioid-related overdose risk
2019 · Addiction Science & Clinical Practice · 189 citations
https://doi.org/10.1186/s13722-019-0145-5
Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder
2015 · Addiction Science & Clinical Practice · 96 citations
https://doi.org/10.1186/s13722-014-0023-0
Illicit substance use after release from prison among formerly incarcerated primary care patients: a cross-sectional study
2019 · Addiction Science & Clinical Practice · 52 citations
https://doi.org/10.1186/s13722-019-0136-6
Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and Outcomes
2021 · Journal of Addiction Medicine · 46 citations
https://doi.org/10.1097/adm.0000000000000934
Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature
2023 · Addiction Science & Clinical Practice · 27 citations
https://doi.org/10.1186/s13722-023-00394-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat